Clinical trials for new minimally invasive technologies have the potential for improved recovery times and reduced pain for patients with aortic arch conditions. Baylor Scott & White The Heart Hospital – Plano is the major center for clinical trials for diseases of the aorta in North Texas, and their work has put them at the forefront of minimally invasive therapies.
Researchers at Baylor Scott & White recently co-authored a paper published in CardioRenal Medicine addressing RAASi applications for acute heart failure patients.
Two Baylor Scott & White sites are participating in a phase III trial examining the safety and efficacy of a device designed to electrically block nerve signals and alleviate pain. Use of this device is being studied in association with providing an effective, mechanism-based yet non-destructive, treatment for managing intractable limb pain in amputees. These locations are the only two sites in the state of Texas selected to participate in this trial.
Findings from a recent study demonstrate a significant correlation between the sonic hedgehog (sHH) signaling pathway and pancreatic cancer (PC) pain. BSWRI researcher Erxi Wu, Ph.D. was among the researchers who led this work and helped author a paper detailing the findings, which was published in Regional Anesthesia & Pain Medicine.
BSWRI researcher Erxi Wu, Ph.D. recently co-authored a paper published in Therapeutic Advances in Medical Oncology, which offered research perspectives on the targeting of SLIT/ROBO pathways. The paper, titled “Targeting the SLIT/ROBO pathway in tumor progression: molecular mechanisms and therapeutic perspectives” was written in collaboration with researchers at Xi’an Jiaotong University in China.
